{"id":"https://openalex.org/W2528658183","doi":"https://doi.org/10.1182/blood.v126.23.1987.1987","title":"Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide (Bu/Cy/VP) Produces Comparable Outcomes to 4-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)","display_name":"Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide (Bu/Cy/VP) Produces Comparable Outcomes to 4-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation (ASCT)","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2528658183","doi":"https://doi.org/10.1182/blood.v126.23.1987.1987","mag":"2528658183"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.1987.1987","doi":"https://doi.org/10.1182/blood.v126.23.1987.1987","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1987.1987","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006235077","display_name":"Brian Thomas Hill","orcid":"https://orcid.org/0000-0001-8781-3327","observed_orcids":["https://orcid.org/0000-0001-8781-3327"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian T. Hill","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046052708","display_name":"Lisa A Rybicki","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]},{"id":"https://openalex.org/I4405287411","display_name":"Cleveland Clinic Research","ror":"https://ror.org/053229s83","country_code":"US","type":"facility","lineage":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Lisa A. Rybicki","raw_affiliation_strings":["Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quantitative Health Sciences, Cleveland Clinic Lerner Research Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111699452","display_name":"Catherine Weber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Catherine Weber","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013162117","display_name":"Deepa Jagadeesh","orcid":"https://orcid.org/0000-0002-1772-0659","observed_orcids":["https://orcid.org/0000-0002-1772-0659"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deepa Jagadeesh","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023728016","display_name":"Aaron Thomas Gerds","orcid":"https://orcid.org/0000-0002-3422-1309","observed_orcids":["https://orcid.org/0000-0002-3422-1309"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron T. Gerds","raw_affiliation_strings":["Leukemia Program, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia Program, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050880000","display_name":"Betty K. Hamilton","orcid":"https://orcid.org/0000-0003-1252-6539","observed_orcids":["https://orcid.org/0000-0003-1252-6539"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Betty K. Hamilton","raw_affiliation_strings":["Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplant Program, Department of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]},{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027255999","display_name":"Hien K. Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hien K. Liu","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011431831","display_name":"Robert M. Dean","orcid":"https://orcid.org/0000-0003-2559-563X","observed_orcids":["https://orcid.org/0000-0003-2559-563X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert M. Dean","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011655907","display_name":"Ronald M. Sobecks","orcid":"https://orcid.org/0000-0003-1608-3261","observed_orcids":["https://orcid.org/0000-0003-1608-3261"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald M. Sobecks","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013767912","display_name":"Brad L. Pohlman","orcid":"https://orcid.org/0000-0001-6006-3714","observed_orcids":["https://orcid.org/0000-0001-6006-3714"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brad Pohlman","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112225519","display_name":"Steven Ware Andresen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Andresen","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112129467","display_name":"Matt E Kalaycio","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matt Kalaycio","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109109837","display_name":"Brian James Bolwell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brian J. Bolwell","raw_affiliation_strings":["Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019494133","display_name":"Navneet S. Majhail","orcid":"https://orcid.org/0000-0001-7082-891X","observed_orcids":["https://orcid.org/0000-0001-7082-891X"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Navneet S. Majhail","raw_affiliation_strings":["Taussig Cancer Institute, Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Taussig Cancer Institute, Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5046052708","https://openalex.org/A5111699452"],"corresponding_institution_ids":["https://openalex.org/I1316902750","https://openalex.org/I4405287411"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.26488501,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"126","issue":"23","first_page":"1987","last_page":"1987"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9560999870300293,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.037300001829862595,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10373","display_name":"Renal Transplantation Outcomes and Treatments","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2747","display_name":"Transplantation"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/high-dose-busulfan","display_name":"high-dose busulfan","score":0.8199999928474426},{"id":"https://openalex.org/keywords/cyclophosphamide","display_name":"cyclophosphamide","score":0.8949999809265137},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.984000027179718},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.8840000033378601},{"id":"https://openalex.org/keywords/hodgkin-lymphoma","display_name":"Hodgkin's disease","score":0.9419999718666077},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.4320000112056732},{"id":"https://openalex.org/keywords/dosing-frequency","display_name":"dosing frequency","score":0.734000027179718},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.6420000195503235},{"id":"https://openalex.org/keywords/dose-monitoring","display_name":"dose monitoring","score":0.5080000162124634},{"id":"https://openalex.org/keywords/treatment-related-mortality","display_name":"non-relapse mortality","score":0.75}],"concepts":[{"id":"https://openalex.org/C2780611847","wikidata":"https://www.wikidata.org/wiki/Q348922","display_name":"Busulfan","level":4,"score":0.9184316396713257},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8365029096603394},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.7161141037940979},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6065833568572998},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5115829110145569},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.511419951915741},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.46857500076293945},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4672785997390747},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.4669056534767151},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4438391327857971},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.41357868909835815},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3408180773258209},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3314233422279358}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.1987.1987","doi":"https://doi.org/10.1182/blood.v126.23.1987.1987","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.1987.1987","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2461809666","https://openalex.org/W2554440676","https://openalex.org/W2587335063","https://openalex.org/W2558885752","https://openalex.org/W2012967987","https://openalex.org/W110982080","https://openalex.org/W2913707766","https://openalex.org/W2083514631","https://openalex.org/W2090767166","https://openalex.org/W2588872766"],"abstract_inverted_index":{"Abstract":[0],"INTRODUCTION:":[1],"High":[2],"dose":[3,137,229,556],"busulfan":[4],"(Bu)":[5],"is":[6,505,530],"an":[7,233,646,659,671,684],"integral":[8],"component":[9],"of":[10,27,34,56,79,138,176,214,230,277,309,321,326,332,378,380,452,472,483,534,542,553,588,649,662,674,687],"many":[11],"commonly-used":[12],"preparative":[13,61],"regimens":[14,324],"for":[15,63,149,169,211,493,548,599,620],"both":[16,312,316],"allogeneic":[17],"and":[18,25,68,118,120,130,186,195,200,206,261,274,282,301,325,395,418,461,514,597,618],"autologous":[19],"transplantation.":[20],"Data":[21],"on":[22,115,127,164,645,658,670,683],"the":[23,227,264,268,330,354,372,381,399,436,453],"efficacy":[24],"toxicity":[26,379],"q6":[28,49,87,142,281,359,400,437,509,589,608,629],"vs.":[29,362,443,609,630],"q24":[30,51,80,218,283,355,402,414,439,559,591,610,631],"hour":[31,611,632],"dosing":[32,53,82,374,383,455,471,500,565,567,593],"are":[33],"significant":[35,388,465,532],"clinical":[36,551],"interest.":[37],"In":[38,209,376],"order":[39],"to":[40,50,335,358],"facilitate":[41],"a":[42,136,212,306,336,481,491,531,539],"therapeutic":[43,555],"dose-monitoring":[44],"protocol,":[45],"we":[46,220],"transitioned":[47],"from":[48,101,174],"Bu":[52,81,132,223,231,266,284,473,499,535,560,592,613,634],"as":[54,124,490],"part":[55],"our":[57,549],"standard":[58,540],"Bu/Cy/VP":[59,605,626],"ASCT":[60,100,603,624],"regimen":[62,352],"patients":[64,97,106,150,216,278,601,622],"with":[65,103,232,280,305,413,469,480,503,526,538,558,604,607,625,628],"Hodgkin":[66],"(HL)":[67],"Non-Hodgkin":[69],"Lymphoma":[70],"(NHL)":[71],"in":[72,311,315,338,346,353,371,390,398,435,467,501,516,519],"July":[73],"2012.":[74],"We":[75,90,463],"present":[76],"comparative":[77],"outcomes":[78,451,587],"vs":[83,401,590],"historical":[84],"controls":[85],"receiving":[86,217],"Bu.":[88],"METHODS":[89],"retrospectively":[91],"reviewed":[92],"400":[93],"consecutive":[94],"eligible":[95],"lymphoma":[96,600,621],"who":[98],"underwent":[99],"2007-2013":[102],"Bu/Cy/VP.":[104],"All":[105],"received":[107],"Cy":[108],"60":[109,122],"mg/kg":[110,123,141,157],"IV":[111],"over":[112],"4":[113],"hours":[114,160],"days":[116,128,165],"-3":[117],"-2":[119],"VP":[121],"continuous":[125],"infusion":[126],"-5":[129],"-4.":[131],"was":[133,191,290,342,386,433],"given":[134],"at":[135,202,329,406],"either":[139,520],"0.8":[140],"(N":[143,161],"=":[144,162],"307)":[145],"x":[146],"14":[147],"doses":[148,368],"transplanted":[151],"between":[152],"2007-July,":[153],"2012":[154],"or":[155,392,522,651,664,676,689],"2.8":[156],"q":[158],"24":[159],"93)":[163],"-9":[166],"through":[167],"-6":[168],"subsequent":[170,494],"patients.":[171],"Outcomes":[172],"assessed":[173,192],"date":[175],"transplant":[177,397],"were:":[178],"relapse,":[179],"non-relapse":[180],"mortality":[181],"(NRM),":[182],"relapse-free":[183],"survival":[184,188],"(RFS)":[185],"overall":[187],"(OS).":[189],"Toxicity":[190],"using":[193,240],"pulmonary":[194,523],"liver":[196],"function":[197],"tests":[198],"(PFTs":[199],"LFTs)":[201],"specified":[203],"time-points":[204],"before":[205,394],"after":[207,226,396],"ASCT.":[208,333],"addition,":[210],"subset":[213],"22":[215],"Bu,":[219,415],"measured":[221,405],"serial":[222],"serum":[224],"levels":[225],"first":[228],"in-house":[234],"liquid":[235],"chromatography-tandem":[236],"mass":[237],"spectrometry":[238],"assay":[239],"turbulent":[241],"flow":[242],"online":[243],"extraction":[244],"technology":[245],"(Bunch,":[246],"et":[247],"al.":[248],"J":[249],"Chromatogr":[250],"B":[251],"Analyt":[252],"Technol":[253],"Biomed":[254],"Life":[255],"Sci,":[256],"2010.":[257],"878(31):":[258],"p.":[259],"3255-8)":[260],"subsequently":[262],"determined":[263],"cumulative":[265],"area-under":[267],"curve":[269],"(AUC).":[270],"RESULTS":[271],"Baseline":[272],"patient":[273],"disease":[275],"characteristics":[276],"dosed":[279],"were":[285,296,369,410,426,457],"similar.":[286],"The":[287,430],"median":[288,431,482],"age":[289],"55":[291],"(range":[292],"20-78)":[293],"years;":[294],"63%":[295,574],"males.":[297],"18%":[298],"had":[299,303,318],"HL":[300],"82%":[302],"NHL":[304],"comparable":[307,319,458],"distribution":[308],"subtypes":[310],"groups.":[313],"Patients":[314],"groups":[317],"rates":[320],"prior":[322],"chemotherapy":[323],"complete/partial":[327],"remission":[328],"time":[331,408],"Due":[334],"change":[337],"institutional":[339],"guidelines,":[340],"plerixafor":[341],"more":[343,506],"commonly":[344],"incorporated":[345],"peripheral":[347],"blood":[348],"stem":[349],"cell":[350],"mobilization":[351],"group":[356,440],"compared":[357],"cohort":[360],"(70%":[361],"39%,":[363],"P":[364,446],"<0.001).":[365],"However,":[366],"CD34+":[367],"same":[370],"two":[373,382,454],"cohorts.":[375,403],"terms":[377],"approaches,":[384],"there":[385,529],"no":[387,517],"difference":[389,425],"FEV1":[391],"DLCO":[393],"LFTs":[404],"four":[407],"points":[409],"generally":[411],"lower":[412],"particularly":[416],"AST":[417],"alkaline":[419],"phosphatase":[420],"(P=0.007":[421],"each),":[422],"but":[423],"these":[424],"not":[427],"clinically":[428],"significant.":[429],"follow-up":[432],"longer":[434],"than":[438,508],"(48.2":[441],"months":[442],"21.3":[444],"months,":[445],"<":[447],"0.001).":[448],"18":[449,585],"month":[450,586],"cohorts":[456],"(see":[459],"Table":[460,562],"Figure).":[462],"observed":[464],"variation":[466],"AUC":[468,536],"weight-based":[470,612,633],"(AUC":[474],"range":[475,533],"12,104":[476],"-":[477],"23,084":[478],"\u00b5M-min)":[479],"17,568":[484],"\u00b5M":[485],"-min,":[486],"which":[487],"has":[488,511],"served":[489],"baseline":[492],"therapeutic-dose":[495],"monitoring.":[496],"CONCLUSIONS":[497],"Q24":[498,566],"combination":[502],"Cy/VP":[504],"convenient":[507],"hours,":[510],"equivalent":[512],"outcomes,":[513],"results":[515],"increase":[518],"hepatic":[521],"toxicity.":[524],"Consistent":[525],"previous":[527],"reports,":[528],"levels,":[537],"deviation":[541],"12%.":[543],"These":[544],"data":[545],"provide":[546],"rationale":[547],"prospective":[550],"trial":[552],"real-time":[554],"monitoring":[557],"dosing.":[561,614,635],"1.":[563,595,616],"Q6":[564],"P-value":[568],"OS":[569,598,619],"78%":[570],"80%":[571],"0.79":[572],"RFS":[573,596,617],"61%":[575],"0.99":[576],"NRM":[577],"5%":[578],"3%":[579],"0.95":[580],"Relapse":[581],"30%":[582],"36%":[583],"0.46":[584],"Figure":[594,615,636,638],"undergoing":[602,623],"treated":[606,627],"2.":[637,639],"Disclosures":[640],"Hill:":[641],"Janssen:":[642],"Honoraria,":[643,656,668,681],"Membership":[644,657,669,682],"entity's":[647,660,672,685],"Board":[648,661,673,686],"Directors":[650,663,675,688],"advisory":[652,665,677,690],"committees;":[653,666,678],"Seattle":[654],"Genetics:":[655],"Celgene:":[667],"Pfizer:":[679],"Consultancy,":[680],"committees.":[691],"Majhail:Gamida":[692],"Cell":[693],"Ltd.:":[694],"Consultancy;":[695],"Anthem":[696],"Inc.:":[697],"Consultancy.":[698]},"counts_by_year":[],"updated_date":"2026-10-24T09:50:30.924529","created_date":"2016-10-14T00:00:00"}